
|Articles|September 15, 2002
Ocular bacterial treatment in development
Alameda, CA-InSite Vision Inc. and Bausch & Lomb have signed a licensing agree-ment to develop InSite's product ISV-403 for the treatment of ocular bacterial infections.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement























